Icam-1 Quantification
Icam-1 Quantification - Related Videos
08:40
Absolute Quantification of Aβ1-42 in CSF Using a Mass Spectrometric Reference Measurement Procedure
0 Views •
Cited by 5 •
2017
A reference measurement procedure for the absolute quantification of Aβ1-42 in human CSF based on solid-phase extraction and liquid chromatography tandem mass spectrometry is described.
11:45
Imaging of HIV-1 Envelope-induced Virological Synapse and Signaling on Synthetic Lipid Bilayers
0 Views •
Cited by 4 •
2012
This article describes a method to visualize formation of an HIV-1 envelope-induced virological synapse on glass supported planar bilayers by total internal reflection fluorescence (TIRF) microscopy. The method can also be combined with immunofluorescence staining to detect activation and redistribution of signaling molecules that occur during HIV-1 envelope-induced virological synapse formation.
08:44
Invertebrate Lifespan Quantification
0 Views •
2023
Many animals naturally stop growing upon reaching adulthood, after which they undergo aging or "senescence" until dying. The amount of time between an organism\'s birth and death is called its lifespan, which can be influenced by various biological and environmental factors. By exposing organisms to different growth conditions, scientists can better understand the factors affecting lifespan. Flies and worms are ideal organisms to perform such experiments, given their short generation time and...
06:13
Enzyme-linked Immunospot Assay (ELISPOT): Quantification of Th-1 Cellular Immune Responses Against Microbial Antigens
0 Views •
Cited by 3 •
2010
Identification of microbial targets of adaptive immunity in idiopathic diseases can be accomplished by the use of the enzyme-linked immunospot assay.
09:32
Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1+ Tim-3+ CD8+ T Cells
0 Views •
Cited by 16 •
2018
Studying tumor microenvironment may identify prognostic or predictive biomarkers of clinical response to immunotherapy. Presented here, is an innovative method based on in situ fluorescence multispectral imaging to analyze and count automatically various subpopulations of CD8+ T cells. This reproducible and reliable technique is suitable for large cohort analyses.
FAQs
A higher or lower ICAM-1 measurement can indicate altered cellular activation or inflammatory signaling. In immunology, the result is especially relevant because ICAM-1 contributes to leukocyte adhesion, while changes on endothelial cells can reflect processes associated with immune-cell recruitment. Thus, the measurement connects molecular expression changes with inflammatory behavior in the studied cells or samples.
The biological source determines what the result represents. Cell-surface measurements describe the abundance of ICAM-1 on individual cells, whereas measurements in biological samples report ICAM-1 detected within that sample. Keeping these contexts distinct helps researchers relate the value either to cellular activation or to inflammation-associated changes present in the sampled material.
Specific antibodies provide the recognition step by binding ICAM-1, while standards or controls give the signal a basis for interpretation. Comparing the measured signal or concentration with these references supports estimation of expression levels and helps evaluate whether observed differences reflect meaningful variation between experimental conditions, such as stimulated and untreated samples.
A typical workflow applies an antibody that specifically recognizes ICAM-1, detects the resulting signal, and compares that signal or concentration with appropriate standards or controls. Flow cytometry, immunoassay, and immunoblotting provide alternative formats for this analysis. The selected format should match whether the experiment focuses on cell-surface abundance or ICAM-1 in a biological sample.
Researchers can compare ICAM-1 levels under conditions associated with pathogen exposure or infection-related inflammation. Changes in the measurement provide a readout of cellular or endothelial activation and can help characterize how inflammatory signaling is altered. In this context, the result supports analysis of disease mechanisms linked to immune-cell adhesion and recruitment.
Measuring ICAM-1 after cytokine exposure or treatment with a therapeutic compound can show whether the condition changes inflammatory activation. Comparing signals or concentrations across experimental groups helps determine treatment-associated effects and may clarify whether a compound influences processes related to endothelial activation, leukocyte adhesion, or immune-cell recruitment. This makes the assay useful for disease and response studies.